Bill · H.Res. 396· House(119-HRES-396)
Expressing support for the designation of the week of May 4, 2025, through May 10, 2025, as "Tardive Dyskinesia Awareness Week".
- Introduced
- 5/7/2025
- Last activity
- 5/7/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Scott Peters
- Cosponsors
- - 1 - 2
- Introduced
- In Committee
A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.
What this bill would do
H. Res. 396 is a resolution that expresses support for designating the week of May 4, 2025, through May 10, 2025, as "Tardive Dyskinesia Awareness Week". The bill aims to raise awareness about tardive dyskinesia (TD), an involuntary movement disorder associated with the prolonged use of certain medications. It encourages people in the United States to become better informed about the condition.
Yes· 3 of 4
Would people with disabilities be better off under this?+3
Provides positive awareness and potential for improved diagnosis for those with a physical movement disorder.
Does this make mental health care easier to get?+2
Increases awareness of a condition often linked to mental health medications, potentially leading to better care.
Does this make health care easier to get in general?+2
Encourages better diagnosis and monitoring of TD by healthcare providers.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Public Awareness: By designating an awareness week and encouraging individuals to become better informed, the resolution aims to raise awareness about TD symptoms (Resolution Section 2).
-
Improved Diagnosis: Since an estimated 65 percent of people with TD have not been diagnosed, raising awareness can help people identify symptoms and seek medical attention (Whereas clause 4).
-
Support for Treatment: The resolution highlights that FDA-approved treatments exist and that recognizing and treating TD can positively impact those with mood and psychotic disorders (Whereas clause 6).
Potential Negative Impacts for People
- No negative impacts for people are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Healthcare Access+2Improves Mental Health Access+2
- Demographic And Interest Groups
- Good For People With Disabilities+3
- Social Issues And Justice
- Improves Disability Rights+2
- 5/7/2025
- Submitted in House
- Referred to the House Committee on Energy and Commerce.
- 3 Cosponsors added.
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Gus BilirakisRepublican · Florida
Aaron BeanRepublican · Florida
Kevin MullinDemocrat · California